RESUMEN
We have investigated the mechanisms that control MHC class II (MHC II) expression in immature and activated dendritic cells (DC) grown from spleen and bone marrow precursors. Degradation of the MHC II chaperone invariant chain (Ii), acquisition of peptide cargo by MHC II, and delivery of MHC II-peptide complexes to the cell surface proceeded similarly in both immature and activated DC. However, immature DC reendocytosed and then degraded the MHC II-peptide complexes much faster than the activated DC. MHC II expression in DC is therefore not controlled by the activity of the protease(s) that degrade Ii, but by the rate of endocytosis of peptide-loaded MHC II. Late after activation, DC downregulated MHC II synthesis both in vitro and in vivo.
Asunto(s)
Presentación de Antígeno/inmunología , Antígenos de Diferenciación de Linfocitos B/inmunología , Células Dendríticas/inmunología , Regulación de la Expresión Génica , Genes MHC Clase II , Antígenos de Histocompatibilidad Clase II/inmunología , Animales , Antígenos de Diferenciación de Linfocitos B/biosíntesis , Células de la Médula Ósea/citología , Células de la Médula Ósea/inmunología , Catepsinas/metabolismo , Membrana Celular/metabolismo , Células Cultivadas , Células Dendríticas/citología , Endocitosis/inmunología , Antígenos de Histocompatibilidad Clase II/biosíntesis , Ratones , Ratones Noqueados , Péptidos/inmunologíaRESUMEN
Despite extensive study of the numerous immunoregulatory mechanisms that contribute to the 'immune-privileged'nature of the anterior chamber (AC) of the eye, little is known of the functional nature of antigen-presenting cells (APC) present in the tissues adjoining the AC. In the present study, we have compared the antigen-presenting capacity of dendritic cells (DC) and macrophages isolated from the normal rat iris. Whereas iris DC exhibited a potent ability to stimulate resting allogeneic T cells in MLR cultures (an in-vitro correlate of the ability to induce primary T cell responses), resident iris macrophages displayed negligible MLR-stimulatory capacity. Significantly, iris macrophages could efficiently elicit proliferation of primed antigen-specific T cells (an in-vitro correlate of the ability to act as local APC in secondary responses). This antigen-presenting activity was approximately half that of fully 'mature' iris DC and considerably greater than that of freshly isolated iris DC. A key contributor to the effectiveness of resident iris macrophage antigen presentation was considered to be the absence of lymphocytostatic control of T cell proliferation exerted by these cells. The results indicate dichotomous but complementary roles for DC (immune surveillance) and macrophages (local antigen presentation in secondary responses) in this tissue.
Asunto(s)
Presentación de Antígeno/inmunología , Células Dendríticas/inmunología , Iris/citología , Macrófagos/inmunología , Animales , Antígenos/inmunología , Separación Celular , Células Cultivadas , ADN/biosíntesis , Activación de Linfocitos/inmunología , Prueba de Cultivo Mixto de Linfocitos , Masculino , Ovalbúmina/inmunología , Ratas , Ratas Endogámicas Lew , Linfocitos T/inmunologíaRESUMEN
Dendritic cells (DC) are considered to be the major cell type responsible for induction of primary immune responses. While they have been shown to play a critical role in eliciting allosensitization via the direct pathway, there is evidence that maturational and/or activational heterogeneity between DC in different donor organs may be crucial to allograft outcome. Despite such an important perceived role for DC, no accurate estimates of their number in commonly transplanted organs have been reported. Therefore, leukocytes and DC were visualized and enumerated in cryostat sections of normal mouse (C57BL/10, B10.BR, C3H) liver, heart, kidney and pancreas by immunohistochemistry (CD45 and MHC class II staining, respectively). Total immunopositive cell number and MHC class II+ cell density (C57BL/10 mice only) were estimated using established morphometric techniques--the fractionator and disector principles, respectively. Liver contained considerably more leukocytes (approximately 5-20 x 10(6)) and DC (approximately 1-3 x 10(6)) than the other organs examined (pancreas: approximately 0.6 x 10(6) and approximately 0.35 x 10(6); heart: approximately 0.8 x 10(6) and approximately 0.4 x 10(6); kidney approximately 1.2 x 10(6) and 0.65 x 10(6), respectively). In liver, DC comprised a lower proportion of all leukocytes (approximately 15-25%) than in the other parenchymal organs examined (approximately 40-60%). Comparatively, DC density in C57BL/10 mice was heart > kidney > pancreas >> liver (approximately 6.6 x 10(6), 5 x 10(6), 4.5 x 10(6) and 1.1 x 10(6) cells/cm3, respectively). When compared to previously published data on allograft survival, the results indicate that the absolute number of MHC class II+ DC present in a donor organ is a poor predictor of graft outcome. Survival of solid organ allografts is more closely related to the density of the donor DC network within the graft.
Asunto(s)
Células Dendríticas/citología , Trasplante de Corazón/inmunología , Trasplante de Riñón/inmunología , Trasplante de Hígado/inmunología , Trasplante de Páncreas/inmunología , Animales , Recuento de Células , Células Dendríticas/inmunología , Femenino , Antígenos de Histocompatibilidad Clase II , Antígenos Comunes de Leucocito , Leucocitos/citología , Leucocitos/inmunología , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos C57BLRESUMEN
Traditional investigations of hepatic dendritic cells (DC) have focused on immunohistochemical studies of these cells within normal and pathological liver tissue. The recent availability of reagents for the improved characterization of DC, together with cytokine-based methods for the expansion of liver DC both in vivo and in vitro have begun to provide new insight into the immunobiology of these important antigen-presenting cells. Hepatic DC probably play a key role in the host response to blood-borne pathogens, and in the pathogenesis of infectious and autoimmune liver diseases. They appear to be important in determining the balance between liver transplant tolerance and rejection. Their possible role in oral and portal venous tolerance remains to be defined. In this article, we focus on emerging aspects of hepatic DC immunobiology, with particular reference to liver transplantation.
Asunto(s)
Células Dendríticas/inmunología , Trasplante de Hígado/inmunología , Hígado/inmunología , Animales , Movimiento Celular/fisiología , Células Dendríticas/fisiología , Humanos , Hígado/citología , Hepatopatías/inmunología , Resultado del TratamientoRESUMEN
Livers transplanted across major histocompatibility complex (MHC) barriers in mice are normally accepted without recipient immune suppression, and induce a state of functional tolerance. However, markedly increasing functional dendritic cells (DC) in the 'passenger leucocyte' population by donor pretreatment with the hematopoietic growth factor Flt3-ligand (Flt3L; 10 microg/day for 10 days) results in acute allograft rejection. In this study, molecular, immunohistochemical and flow cytometric analysis of donor cell traffick into recipient lymphoid tissue 24 h after liver transplantation (C57BL/10 [H2b]-->C3H [H2k]) was performed. In addition, the capacity of donor-derived cells in these tissues to stimulate host T cell proliferation was examined. Reverse transcriptase polymerase chain reaction analysis revealed increases in donor genomic DNA in both thymi and spleens of mice given livers from Flt3L-treated donors compared to controls. Donor MHC class II+ (IAb+) cells in spleens were strikingly elevated (10-fold) in the former group. Two-colour flow cytometry revealed a similar increase in donor-derived H-2Kb+/I-Ab+ cells, and in the incidence of donor leucocytes expressing CD40, CD80, and CD86. CD11c+ DC comprised approximately 40% of the I-Ab+ cells in spleens of mice given livers from Flt3L-treated donors. These changes were associated with the presence, in spleens, of potent allostimulatory activity for naive recipient strain T cells, that was not observed in normal liver recipients. Elicitation of allograft rejection, associated with enhanced trafficking of stimulatory donor antigen-presenting cells (APC), in particular DC, suggests that normal liver graft survival and tolerance induction may be linked to failure/counter-regulation of APC-driven stimulation of effective anti-donor T cell responses.
Asunto(s)
Células Presentadoras de Antígenos/inmunología , Rechazo de Injerto/inmunología , Tolerancia Inmunológica/inmunología , Trasplante de Hígado/inmunología , Proteínas de la Membrana/inmunología , Animales , Antígenos CD/inmunología , Antígeno B7-1/inmunología , Antígeno B7-2 , Antígenos CD40/inmunología , Células CHO , División Celular , Cricetinae , Antígenos de Histocompatibilidad Clase II/inmunología , Humanos , Hígado/citología , Tejido Linfoide/citología , Tejido Linfoide/inmunología , Masculino , Glicoproteínas de Membrana/inmunología , Proteínas de la Membrana/administración & dosificación , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Bazo/citología , Bazo/inmunología , Linfocitos T/citología , Donantes de Tejidos , Trasplante HomólogoRESUMEN
The generation and activity of NK cells appear to be regulated by a particular set of cytokines. We examined the in vivo effects of recombinant human Flt3 ligand (Flt3-L), a recently cloned potent hemopoietic cytokine, on NK cell development in mice. Daily i.p. administration of Flt3-L consistently induced striking increases in both the absolute number and the total cytotoxic activity of mature nonactivated NK cells within various tissues. Dose- and time-dependent increases were observed in the bone marrow (approximately 2- and approximately 11-fold, respectively), thymus (approximately 2.8- and approximately 2.0-fold), blood (approximately 11- and approximately 15-fold), spleen (approximately 10- and approximately 9-fold), and liver (approximately 15- and approximately 39-fold). In addition, IL-2 induced a rapid increase in NK activity, NK cell proliferative responses, generation of lymphokine-activated killer activity, and development of activated adherent NK cells, which were all significantly increased by Flt3-L treatment. Thus, in addition to its recently reported capacity to stimulate dendritic cell production, Flt3-L has a prominent biologic role in NK cell generation in vivo. This is probably a result of selectively induced expansion of NK cell progenitors (pro-NK cells), because Flt3-L stimulates in vitro proliferation of pro-NK cells without affecting the cytotoxicity of mature NK cells. The results also indicate that either alone or in combination with a potent activator of NK cells, such as IL-2, Flt3-L could be used to markedly augment the number and activity of NK cells, especially in the liver. Flt3-L appears to have considerable potential for therapy of both cancer and viral infection.
Asunto(s)
Adyuvantes Inmunológicos/farmacología , Antineoplásicos/farmacología , Antivirales/farmacología , Hematopoyesis/inmunología , Células Asesinas Naturales/inmunología , Proteínas de la Membrana/administración & dosificación , Adyuvantes Inmunológicos/administración & dosificación , Animales , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/inmunología , Citotoxicidad Inmunológica/efectos de los fármacos , Células Dendríticas/citología , Relación Dosis-Respuesta Inmunológica , Hematopoyesis/efectos de los fármacos , Humanos , Inyecciones Intraperitoneales , Interleucina-2/farmacología , Células Asesinas Naturales/citología , Cinética , Ligandos , Activación de Linfocitos/efectos de los fármacos , Recuento de Linfocitos/efectos de los fármacos , Proteínas de la Membrana/uso terapéutico , Ratones , Ratones Endogámicos C57BL , Especificidad de Órganos/inmunología , Péptidos/inmunología , Subgrupos de Linfocitos T/citologíaRESUMEN
BACKGROUND: Liver allografts are accepted across major histocompatibility complex (MHC) barriers in mice and induce donor-specific tolerance without requirement for immunosuppressive therapy. There is evidence that passenger leukocytes may play a key role in tolerance induction. Flt-3 ligand (FL) is a recently cloned hematopoietic cytokine that strikingly augments functional dendritic cells (DCs) within lymphoid and nonlymphoid tissue. METHODS: The expression of costimulatory molecules and MHC class II antigen on DCs isolated from livers of FL-treated B10 (H2b) mice (10 microg/day; 10 days) was examined by flow cytometric analysis, and their allostimulatory activity assessed in primary mixed leukocyte cultures. B10 livers from FL-treated donors were transplanted orthotopically into naive C3H (H2k) recipients. Donor cells (MHC class II+) in recipient spleens were identified by immunohistochemistry. Antidonor cytotoxic T lymphocyte activity, and both natural killer and lymphokine-activated killer cell activities of graft nonparenchymal cells and host splenocytes were determined using isotope release assays. Apoptotic activity within liver grafts was determined by terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling. RESULTS: DCs isolated from livers of FL-treated donor mice exhibited increased cell surface expression of CD40, CD80, CD86, and IAb, and augmented T cell allostimulatory activity compared with controls. Within 24 hr of organ transplantation, the numbers of donor IAb+ cells within recipient spleens was augmented substantially compared with normal liver recipients. Livers from FL-treated donors were rejected acutely (median survival time, 5 days), whereas control B10 liver allografts survived >100 days. Nonparenchymal cells from rejecting grafts 4 days after transplantation exhibited increased antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities compared with cells from spontaneously accepted grafts. This augmented cytotoxic reactivity was associated with histologic evidence of injury to bile duct epithelium and vascular endothelium that was not readily evident in controls. CONCLUSION: Thus, although normal livers provide allostimulatory signals sufficient to elicit an antidonor immune response, regulatory mechanisms that may include apoptosis of graft-infiltrating T cells, and that are overcome by augmenting the number of functional donor DCs, may account for inherent liver tolerogenicity.
Asunto(s)
Apoptosis , Células Asesinas Activadas por Linfocinas/inmunología , Células Asesinas Naturales/inmunología , Trasplante de Hígado/inmunología , Proteínas de la Membrana/farmacología , Linfocitos T Citotóxicos/inmunología , Animales , Conductos Biliares/patología , Células Dendríticas/fisiología , Rechazo de Injerto , Antígenos de Histocompatibilidad Clase II/análisis , Hígado/patología , Masculino , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Trasplante HomólogoRESUMEN
C3H (H2k) mice received 50 x 10(6) B10 (H2b) bone marrow (BM) cells either alone or with flt-3 ligand (FL) (10 microg/day), tacrolimus (2 mg/kg/day), or both agents for 7 days. Donor MHC class II+ (IAb+) cells were quantitated in spleens by immunohistochemical analysis, and donor class II DNA detected in BM by PCR. Donor cells were rare in the BM alone and BM + FL groups, whereas there was a substantial increase in chimerism in the BM + tacrolimus group. Addition of FL to BM + tacrolimus led to a further eightfold increase in donor cells and enhanced donor DNA compared with the BM + tacrolimus group. This increase in donor cells was almost 500-fold compared with BM alone. C3H recipients of B10 heart allografts given perioperative B10 BM and tacrolimus (days 0-13) exhibited a markedly extended median graft survival time (MST, 42 days) compared with those given tacrolimus alone (MST, 22 days). Addition of FL (10 microg/day; 7 days) to BM + tacrolimus prevented the beneficial effect of donor BM (MST, 18 days). BM alone or BM + FL resulted in uniform early heart graft failure (MST < 8 days). Functional studies revealed maximal antidonor MLR and CTL activities in the BM- and BM + FL-treated groups, with minimal activity in the tacrolimus-treated groups. Thus, dramatic growth factor-induced increases in chimerism achieved under cover of immunosuppression may result in augmented antidonor T cell reactivity and reduced graft survival after immunosuppressive drug withdrawal. With FL, this may reflect striking augmentation of immunostimulatory dendritic cells.
Asunto(s)
Trasplante de Médula Ósea/inmunología , Quimera/inmunología , Trasplante de Corazón/inmunología , Proteínas de la Membrana/farmacología , Animales , Secuencia de Bases , Cartilla de ADN/genética , Genes MHC Clase II , Supervivencia de Injerto/efectos de los fármacos , Supervivencia de Injerto/inmunología , Antígenos de Histocompatibilidad Clase II/metabolismo , Inmunosupresores/farmacología , Activación de Linfocitos , Masculino , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Reacción en Cadena de la Polimerasa , Linfocitos T/inmunología , Tacrolimus/farmacología , Donantes de Tejidos , Acondicionamiento Pretrasplante/efectos adversos , Acondicionamiento Pretrasplante/métodos , Trasplante IsogénicoRESUMEN
BACKGROUND: The influence of donor hematopoietic cell microchimerism on organ allograft survival has been studied largely in vascularized transplant models. Here, we examine the impact of donor bone marrow (BM) cells administered intravenously together with transient systemic tacrolimus therapy on microchimerism, the survival of nonvascularized cardiac allografts, and growth of donor antigen-presenting cells [dendritic cells (DCs)] from recipient BM. METHODS: Adult male C3H (H2k) mice received heterotopic heart transplants from B10 (H2b) donors in the dorsal ear pinna. They were given no further treatment, or either a short course of tacrolimus (FK506; 2 mg/kg i.p. from day 0 to day 13), unmodified donor BM cells (50x10(6) i.v. on day 0) or both treatments. Grafts were examined daily for contractile activity. Anti-donor cytotoxic T lymphocyte responses were determined in recipients' spleens. Microchimerism (IAb+ cells) was demonstrated by immunocytochemical staining of spleens, and of cells expanded from recipient BM using cytokines and culture conditions that promote the growth of DCs. RESULTS: Tacrolimus alone significantly prolonged median heart graft survival time from 10 to 22 days (P<0.001). BM alone failed to prolong graft survival. By contrast, tacrolimus + donor BM resulted in a mean survival time of 42 days (P<0.01 compared with tacrolimus treatment alone). This marked increase in heart allograft survival was associated with reduced anti-donor cytotoxic T lymphocyte responses attributable to a nonspecific effect of tacrolimus. In addition, however, a link was observed between the beneficial effect of donor BM and comparatively large numbers of donor major histocompatibility complex class II (IAb+)-positive cells in recipients' spleens, and in cultures of granulocyte-macrophage colony-stimulating factor + interleukin-4-stimulated DCs from recipients' BM. No donor-derived cells were propagated from heart graft recipients given either tacrolimus or donor BM alone. CONCLUSIONS: This nonvascularized organ transplant model demonstrates the positive effect on allograft survival of donor BM given at the time of transplant to transiently immunosuppressed recipients. The findings also reveal links between hematopoietic cell chimerism, the presence of donor DC progenitors in recipient BM, and organ allograft survival.
Asunto(s)
Trasplante de Médula Ósea/inmunología , Supervivencia de Injerto/inmunología , Trasplante de Corazón/fisiología , Terapia de Inmunosupresión/métodos , Tacrolimus/uso terapéutico , Animales , Células Cultivadas , Terapia Combinada , Circulación Coronaria , Rechazo de Injerto/prevención & control , Trasplante de Corazón/inmunología , Masculino , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos , Contracción Miocárdica , Bazo/inmunología , Linfocitos T Citotóxicos/inmunología , Factores de Tiempo , Trasplante Heterotópico , Trasplante HomólogoRESUMEN
The influence of the haematopoietic growth factor Flt-3 ligand (FL) on the incidence and function of donor major histocompatibility complex (MHC) class II+ cells in the lymphoid tissues of noncytoablated recipients of heart allografts and donor bone marrow (BM) cells was investigated. C3H (H2k) mice received a nonvascularized B10 (H2b) heart allograft in the dorsal ear pinna, followed by an i.v. infusion of 50 x 10(6) donor BM cells. They were given FL (10 microg/day i.p., x7 days), tacrolimus (2mg/kg/day i.p., x13 days) or both agents immediately following heart transplantation (HTx) and were killed 10 or 21 days later. Their BM cells were propagated in vitro in granulocyte macrophage colony stimulating factor (GM-CSF) and IL-4 for 5 days to promote the growth of dendritic cells (DC). Donor DC were identified by immunocytochemical staining. Spleens were harvested, and donor (IAb+) cells enumerated by immunohistochemical analysis. Donor MHC class II DNA was detected in spleens and cultured BM-derived cells by reverse transcriptase-polymerase chain reaction (RT-PCR). A striking increase in donor MHC class II+ cells was noted in both the spleen and BM of the BM + tacrolimus-treated group compared to either the BM alone, or BM + FL-treated groups. Addition of FL treatment to BM + tacrolimus led to a further increase in donor cells in spleen (three-fold at 10 days, and two-fold at 21 days). The increase in donor cells at 10 days was almost 140-fold compared to that with donor BM alone. PCR analysis at this time revealed enhanced donor DNA in the BM + FL + tacrolimus group compared to that in the BM + tacrolimus group. FL treatment augmented mixed leucocyte reactions (MLR) and cytotoxic T lymphocyte (CTL) activity of host spleen cells against donor alloantigens. These effects were reversed by tacrolimus administration. Histopathology of heart grafts from tacrolimus-treated animals at 10 and 21 days showed absence or substantial reduction in cellular infiltration, and the preservation of viable myocardium. By contrast, in untreated mice, or animals given BM or BM + FL alone, there was marked cellular infiltration, and features of accelerated rejection. Donor-derived DC could be propagated in vitro from the BM of heart transplant recipients given donor BM, especially from mice that also received tacrolimus +/- FL. At day 21, donor-derived cells could only be propagated from the BM + FL + tacrolimus-treated group. These findings show that numbers of donor antigen presenting cells (APC) or their progenitors can be markedly increased in conventionally immunosuppressed organ allograft recipients given donor BM + a potent haematopoietic and DC-growth promoting cytokine. Although withdrawal of systemic immunosuppression appears to allow exhibition of the potential allostimulatory activity of these donor APC leading to rejection, the model provides a useful basis for further evaluation of the persistence and manipulation of donor haematopoietic cells and in particular, donor-derived APC, on the outcome of organ transplantation.
Asunto(s)
Células Presentadoras de Antígenos/trasplante , Trasplante de Médula Ósea/inmunología , Trasplante de Corazón/inmunología , Proteínas de la Membrana/inmunología , Adyuvantes Inmunológicos , Animales , Células Presentadoras de Antígenos/efectos de los fármacos , Células Presentadoras de Antígenos/inmunología , División Celular , ADN/análisis , Células Dendríticas/efectos de los fármacos , Células Dendríticas/inmunología , Inmunosupresores/farmacología , Ligandos , Prueba de Cultivo Mixto de Linfocitos , Masculino , Proteínas de la Membrana/farmacología , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Miocardio/patología , Reacción en Cadena de la Polimerasa/métodos , Bazo/citología , Linfocitos T Citotóxicos/inmunología , Tacrolimus/farmacología , Donantes de Tejidos , Trasplante HomólogoRESUMEN
PURPOSE: To examine the postnatal development of major histocompatibility complex (MHC) class II-positive dendritic cells (DC) in the iris of the normal rat eye. METHODS: Single- and double-color immunomorphologic studies were performed on whole mounts prepared from rat iris taken at selected postnatal ages (2 to 3 days to 78 weeks). Immunopositive cells were enumerated, using a quantitative light microscope, and MHC class II expression on individual cells was assessed by microdensitometric analysis. RESULTS: Major histocompatibility class II-positive DCs in the iris developed in an age-dependent manner and reached adult-equivalent density and structure at approximately 10 weeks of age, considerably later than previously described in other DC populations in the rat. In contrast, the anti-rat DC monoclonal antibody OX62 revealed a population of cells present at adult-equivalent levels as early as 3 weeks after birth. Dual-color immunostaining and microdensitometric analysis demonstrated that during postnatal growth, development of the network of MHC class II-positive DCs was a consequence of the progressive increase in expression of MHC class II antigen by OX62-positive cells. CONCLUSIONS: During postnatal growth, the DC population of the iris develops initially as an OX62-positive-MHC class II-negative population, which then develops increasing MHC class II expression in situ and finally resembles classic DC populations in other tissue sites. Maturation of the iris DC population is temporally delayed compared with time to maturation in other tissue sites in the rat.
Asunto(s)
Células Dendríticas/citología , Antígenos de Histocompatibilidad Clase II/inmunología , Iris/citología , Animales , Anticuerpos Monoclonales , Recuento de Células , Células Dendríticas/inmunología , Inmunohistoquímica , Iris/inmunología , Masculino , Ratas , Ratas Endogámicas LewRESUMEN
Treatment of mice with the recently cloned hemopoietic growth factor Flt3 ligand (FL; 10 microg/day for 10 days) resulted in a large increase in myeloid lineage cells within the liver. While the number of nonparenchymal cells (NPC) harvested from liver increased about 9-fold, a 90-fold increase was observed in the proportion of CD11c+ dendritic cells (DC) recovered from NPC following overnight (18-h) culture in granulocyte-macrophage CSF. In contrast, only a 50% increase was seen in CD11c+ cells within heart single cell suspensions and in the number of DC obtained from hearts after 18-h culture. Liver NPC and heart cell suspensions freshly isolated from 10-day FL-treated animals exhibited increased T cell allostimulatory capacity compared with controls. Overnight cultured DC from livers of FL-treated animals expressed both higher levels of costimulatory molecules (CD80 and CD86) and allostimulatory activity than those from controls. Heart-derived DC also displayed enhanced stimulatory capacity. Pretreatment of organ donors with FL for either 5 or 10 days before transplant of organs to normal recipients abrogated the spontaneous liver allograft acceptance normally observed and resulted in delayed or acute graft rejection (median survival times, 40 and 12 days, respectively). Heart rejection was significantly accelerated by pretreatment of donors with FL for 5 or 10 days (median survival times, 8 and 7 days, respectively, vs 12 days in controls). These novel findings reveal the potent immunologic adjuvant properties of FL in vivo. They also show that substantial augmentation of the number of potential allostimulatory cells in donor organs before transplantation favors rejection rather than tolerance induction.
Asunto(s)
Células Dendríticas/inmunología , Rechazo de Injerto , Supervivencia de Injerto , Trasplante de Corazón/inmunología , Trasplante de Hígado/inmunología , Hígado/efectos de los fármacos , Proteínas de la Membrana/farmacología , Animales , Recuento de Células , Células Madre Hematopoyéticas/efectos de los fármacos , Hígado/inmunología , Masculino , Ratones , Ratones Endogámicos , Miocardio/citología , Miocardio/inmunología , Trasplante HomólogoRESUMEN
Dendritic cells (DC) are widely accepted as the most potent antigen-presenting cells (APC), and considerable interest has been generated in their potential for the immunological therapy of cancer and infectious disease. Recently, however, a broader understanding of the phenotypic diversity and functional heterogeneity of DC has been acquired. Thus, in addition to having a role in central tolerance, DC are now regarded as potential modulators of peripheral immune responses. Harnessing this potential may offer a new approach to the immunosuppressive therapy of allograft rejection or autoimmunity. Here, the concept of "tolerogenic" DC is placed in the context of rapidly accumulating new evidence of the diverse properties of these important APC.
Asunto(s)
Células Dendríticas/inmunología , Tolerancia Inmunológica , Animales , HumanosRESUMEN
Recent studies have identified distinct but co-existing networks of resident tissue macrophages and MHC class II-positive DC present in tissues bordering the anterior chamber of the eye, a site classically regarded as 'immune-privileged'. As the DC network, present at approximately 500 cells/mm2, accounts for virtually all MHC class II immunostaining in these tissues and possesses potent capacity to stimulate primary allogenic responses in vitro, it is proposed that these cells may play an important role in immune surveillance of the anterior chamber. Tissue macrophage and DC population kinetics in the iris were examined by using X-irradiation exposure to interrupt the steady-state renewal of these cells by haematopoietically derived precursors. MHC class II-positive iris DC exhibited a half-life of approximately 3 days, a rapid turnover rate which closely resembled that of DC present in mucosal epithelia. In contrast, the resident tissue macrophage population displayed a considerably slower turnover (half-life of 10-12 days) comparable to that of epidermal Langerhans cells in the present study. Bone marrow transplantation studies confirmed the haematopoietic origin of the iris DC population. The present study provides the first estimates of the steady-state population kinetics of antigen-presenting cell populations in the iris and has important implications for understanding the role of these cells in immunological homeostasis of the anterior chamber.
Asunto(s)
Células Dendríticas/inmunología , Antígenos de Histocompatibilidad Clase II/metabolismo , Iris/citología , Iris/inmunología , Macrófagos/inmunología , Animales , Anticuerpos Monoclonales/análisis , Trasplante de Médula Ósea , Recuento de Células , División Celular/inmunología , División Celular/efectos de la radiación , Células Dendríticas/química , Células Dendríticas/efectos de la radiación , Células Epidérmicas , Células de Langerhans/química , Células de Langerhans/inmunología , Macrófagos/química , Masculino , Ratas , Ratas Endogámicas LewRESUMEN
Recent immunomorphological studies have demonstrated the presence of distinct populations of resident tissue macrophages and major histocompatibility complex (MHC) class II+ dendritic cells within tissues lining the anterior chamber of rat, mouse and human eyes. The location of these cells in sites of potential contact with the aqueous humour-filled anterior chamber suggests that either of these cells may perform a role in immunosurveillance of this 'immune-privileged site'. The aim of the present study was to isolate highly purified dendritic cells and tissue macrophages from enzymatically disaggregated rat irides and to compare their relative capacity to stimulate unprimed T lymphocytes in vitro in a mixed leucocyte reaction assay. Dendritic cells freshly isolated from iris tissue exhibited a moderate ability to stimulate unprimed T lymphocytes. However, following 48 hr of culture in granulocyte-macrophage colony-stimulating factor (GM-CSF)-supplemented medium, MHC class II+ dendritic cells demonstrated a markedly enhanced stimulatory capacity that was identical to that of Langerhans' cells isolated from skin. Tissue macrophages isolated from rat iris, however, demonstrated little allostimulatory capacity, either when freshly isolated or following 48 hr of culture in GM-CSF. This study provides the first definitive evidence that MHC class II+ cells within tissues lining the anterior chamber are functionally equivalent to dendritic cells described in other tissues. These findings have important implications for our understanding of the mechanisms of immune surveillance within the anterior chamber of the eye.
Asunto(s)
Células Dendríticas/inmunología , Antígenos de Histocompatibilidad Clase II/análisis , Iris/inmunología , Macrófagos/inmunología , Ratas Endogámicas/inmunología , Animales , Células Cultivadas , Factor Estimulante de Colonias de Granulocitos y Macrófagos/inmunología , Prueba de Cultivo Mixto de Linfocitos , Masculino , Ratas , Ratas Endogámicas Lew/inmunología , Linfocitos T/inmunologíaRESUMEN
Despite the implication that choroidal mast cells are involved in the onset of experimental autoimmune uveoretinitis (EAU), a widely used animal model of uveoretinitis, little is known of these cells. In the present study the distribution, total number, regional density, and phenotype of choroidal mast cells were examined in Lewis, Wistar Furth, PVG/c, and brown Norway rats. Choroidal mast cells were predominantly associated with arteries and arterioles of more than 30 microns diameter which lie in the outer (sclerad) choroid. The density of mast cells was greatest in the posterior choroid with density diminishing anteriorly. The choroid of male Lewis rats contained significantly greater number of mast cells than that of females (p < 0.01). Histochemical (Alcian blue/safranin) and immunohistochemical (anti-rat mast cell protease I and II monoclonal antibodies) studies revealed choroidal mast cells were of the connective tissue type. However, granule proteinase content appeared less than that of well characterised connective tissue mast cell populations such as those in mesentery and skin. Lewis rats exhibited the highest density of choroidal mast cells (23.6 (SD 1.2)/mm2), Wistar Furth approximately half that of Lewis (13.5 (0.7)/mm2) while PVG/c and brown Norway rats had very low densities (3.06(0.3); 1.95(0.2/mm2 respectively). These studies provide valuable choroidal mast cell data for rats which may have implications for our understanding of experimental models of intraocular inflammation and clinical uveitis.
Asunto(s)
Coroides/citología , Mastocitos , Ratas/anatomía & histología , Animales , Recuento de Células , Coroides/irrigación sanguínea , Coroides/inmunología , Coroides/metabolismo , Femenino , Inmunohistoquímica , Masculino , Mastocitos/metabolismo , Arteria Oftálmica/anatomía & histología , Ratas Endogámicas Lew , Ratas Wistar , Caracteres SexualesRESUMEN
Choroidal mast cells have been implicated in the pathogenesis of experimental autoimmune uveoretinitis (EAU). The aim of the present study was to examine the dynamics of choroidal mast cells during the course of EAU in rat strains of varying susceptibility. Histochemical staining showed choroidal mast cell degranulation in Lewis rats, a highly susceptible strain, commenced nine days post-immunisation, and peaked at day 11, at which time the percentage of degranulated choroidal mast cells (32. 5± 4%) was significantly higher than controls (15. 3 ± 3%; p <0.05). At day 14, mean choroidal mast cell density was significantly reduced (from 23. 6 ± 1/mm(2) tot 16. 2 ± 2/mm(2); p<0.05) and early signs of choroidal mast cell regeneration were evident. Immunisation of PVG/C (moderate susceptibility) and Brown Norway (very low susceptibility) rats produced a similar pattern of morphological changes. Onset of clinical signs in Lewis rats, which possess approximately 1100 to 1800 choroidal mast cells per eye, occurred one day following commencement of choroidal mast cell degranulation but prior to the peak of degranulation. However, in PVG/C and Brown Norway rats, which possess only approximately 70 and 110 choroidal mast cells per eye respectively, onset of disease was not temporally linked to commencement of degranulation. Production of antigen-specific IgE during the course of EAU was extremely low in all three strains. These results indicate that choroidal mast cells may be important in the pathogenesis of EAU in Lewis rats but not in PVG/C or Brown Norway rats and that non-IgE mediated degranulation may play a role in disease induction.
RESUMEN
BACKGROUND: Experimental autoimmune uveitis (EAU) is a highly organ-specific autoimmune disease in which the target is the retinal photoreceptors. It is well recognized as a model of uveoretinitis in humans. The mechanisms that control the homing of sensitized lymphocytes and other leukocytes to the retina is unknown. The aim of this study was to investigate changes in the retinal vasculature that may be involved with aiding leukocyte-endothelial cell interactions and subsequent extravasation of leukocytes into the retina. EXPERIMENTAL DESIGN: Lewis rats immunized with S-antigen were used to produce EAU. The retinal vasculature was assessed by morphologic (light and electron microscopy) and morphometric techniques at various stages in the generation and course of the disease (days 3, 7, 11, 14, 21, 28 and 49 postimmunization) for evidence of endothelial cell (EC) activation and leukocyte-EC interaction. Image analysis of the retinal vessels at the electron microscopic level was performed to detect alterations in the thickness and irregularity of the EC surface, both considered to be important in lymphocyte homing in the high endothelial venules (HEVs) of lymphoid tissues. Control values were obtained from normal eyes, pertussis-only treated animals, and normal lymph node HEVs. RESULTS: The clinical and histopathologic changes in the eyes were consistent with previous descriptions of EAU and included perivasculitis, focal mononuclear infiltrate in the outer retina, and choroid with destruction of the photoreceptor outer segments and eventually loss of large portions of the outer retina. During the course of EAU, a significant proportion of retinal venules underwent both qualitative and quantitative morphologic changes including EC activation evident as increased cytoplasmic organelles, a 230% average increase in mean EC thickness, and a concomitant 4-fold increase in irregularity of the EC, that produced plump irregular EC with deep intercellular clefts. These alterations were maximal at day 21, however from day 11 onward, large numbers of lymphocytes and monocytes were observed adhering to or lodged in the clefts of plump EC, migrating through the EC cytoplasm, or lying beneath the EC. CONCLUSIONS: The characteristics acquired by the retinal venules during EAU are reminiscent of HEVs. This study suggests that tissue-specific changes in the endothelial cells of retinal venules may be responsible for the homing of S-antigen specific autoreactive lymphocytes to the target organ in this model of retinal autoimmunity.
Asunto(s)
Enfermedades Autoinmunes/patología , Endotelio Vascular/patología , Uveítis/patología , Animales , Antígenos/inmunología , Arrestina , Arteriolas/ultraestructura , Capilares/ultraestructura , Endotelio Vascular/inmunología , Proteínas del Ojo/inmunología , Microscopía Electrónica , Ratas , Ratas Endogámicas Lew , Vasos Retinianos/inmunología , Factores de Tiempo , Vénulas/ultraestructuraRESUMEN
The normal functional anatomy of the aqueous humour outflow pathways in the domestic pig is poorly documented in the literature despite its being readily available and of a similar size to the human eye. Anterior segment tissue from 12 pig eyes was appropriately fixed and investigated by light microscopy, and scanning and transmission electron microscopy. The configuration of the iridocorneal angle tissues is similar to other nonprimate mammals in several respects, i.e. it possesses a deep ciliary cleft crossed by stout pectinate ligaments and delicate uveal cords, poorly developed ciliary musculature, and an angular aqueous plexus. However, there were some noteworthy features which may make it a suitable model for specific types of glaucoma related research. These features include a shallow scleral sulcus which contains a wedge-shaped mass of corneoscleral tissue comparable in size to the human trabecular meshwork. This tissue was more trabecular than 'reticular' in arrangement, the latter being the more common in nonprimate mammalian species. The relevance of the present findings to the use and limitations of the porcine eye as a model of the human aqueous outflow pathways is discussed.